Construction and in vitro cytotoxic assay of a novel fusion toxin IL15-PEΔ293

Chinese Journal of Microbiology and Immunology

Volumn 24, Issue 12, 2004, Pages 991-995

  Niu, Yun Fei ^a   Mao, Xiao Hua ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

Exotoxin; Fusion protein; Interleukin 15; Pseudomonas aeruginosa

Indexed keywords

DNA FRAGMENT; HYBRID PROTEIN; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR; PSEUDOMONAS EXOTOXIN; PSEUDOMONAS EXOTOXIN DELTA293; PSEUDOMONAS EXOTOXIN DELTA293 INTERLEUKIN 15; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ARTICLE; CELL TRANSFORMATION; CONCENTRATION RESPONSE; CYTOTOXICITY; DNA SEQUENCE; DOSE RESPONSE; GENE MUTATION; GENE OVEREXPRESSION; MOLECULAR CLONING; MOLECULAR MODEL; MULTIDRUG RESISTANCE; MYELOID LEUKEMIA; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RESTRICTION MAPPING; TOXIN ANALYSIS;

EID: 14744268083     PISSN: 02545101     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Fehniger TA, Caligiuri MA. Interleukin15: biology and relevance to human disease. Blood, 2001, 97: 14-32.
2. McInnes IB, Leung BP, Sturrock RD, et al. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis. Nat Med, 1997, 3: 189-195.
3. Azimi N, Brown K, Bamford RN, et al. Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-κB site. Proc Natl Acad Sci USA, 1998, 95: 2452-2457.
4. Tinhofer I, Marschitz I, Henn T, et al. Expression of functional interleukin-15 receptor and autocrine production of interleukin-15 as mechanisms of tumor propagation in multiple myeloma. Blood, 2000, 95: 610-618.
5. Pastan I, Chaudhary V, FitzGerald DJ. Recombinant toxins as novel therapeutic agents. Annu Rev Biochem, 1992, 61: 331-354.
6. Anderson DM, Kumaki S, Ahdieh M, et al. Functional characterization of the human interleukin-15 receptor α chain and close linkage of IL15RA and IL2RA genes. J Biol Chem, 1995, 270: 29862-29869.
7. Husain SR, Puri RK. Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy; from bench to bedside. J Neurooncol, 2003, 65: 37-48.
8. Pastan I. Immunotoxins containing Pseudomonas exotoxin A: a short history. Cancer Immunol Immunother, 2003, 52: 338-341.
9. Siegall CB, Ogata M, Pastan I, et al. Analysis of sequences in domain II of Pseudomonas exotoxin A which mediate translocation. Biochemistry, 1991, 30: 7154-7159.
10. Bourdenet S, Vacheron MJ, Guinand M, et al. Biochemical and immunochemical studies of proteolytic fragments of exotoxin A from Pseudomonas aeruginosa. Eur J Biochem, 1990, 192: 379-385.
11. Taupiac MP, Bebien M, Alami M, et al. A deletion within the translocation domain of Pseudomonas exotoxin A enhances translocation efficiency and cytotoxicity concomitantly. Mol Microbiol, 1999, 31: 1385-1393.
12. Katsanis E, Xu Z, Panoskaltsis-Mortari A, et al. IL-15 administration following syngeneic bone marrow transplantation prolongs survival of lymphoma bearing mice. Transplantation, 1996, 62: 872-875.
13. Kobayashi H, Carraquillo JA, Paik CH, et al. Differences of biodistribution, pharmacokinetics, and rumor targeting between interleukins 2 and 15. Cancer Res, 2000, 60: 3577-3583.